Héctor Jausàs | Fieldfisher
Skip to main content
Professional background

Professional background

I have extensive knowledge of the legal challenges faced by the pharmaceutical industry in regulatory matters (pricing and reimbursement), advertising, competition law, commercial contracts, data protection, and product liability.

I advise national and international companies in the pharmaceutical, healthcare, cosmetics, and food sectors.

I have been a member of Conférence Bleue since 1997 and served as co-directing partner from 2012 to 2021. I am a member of the Real Academia de Farmacia de Cataluña and a guest lecturer at European Union conferences at the Universidad Carlos III de Madrid, as well as a speaker at the summer courses of the Universidad de Navarra.

I currently advise over 50 national and international companies in the pharmaceutical, healthcare, cosmetics, and food sectors on a regular basis.

I lead the Life Sciences Department at Fieldfisher Spain, which is recognised by Chambers & Partners as one of the leading practices in this field. Chambers & Partners also highlights me as a leading lawyer in regulatory and competition law.

Chambers & Partners has also ranked me as a leading lawyer in Spain for regulatory and competition law (Band 1) in Life Sciences

Since 2005, I have been consistently recognised by Chambers & Partners as a leading lawyer in Life Sciences in Spain.

I am annually recognised by Best Lawyers as one of the top lawyers in my field and was named Best Lawyer of the Year in 2014 and 2016. 

In 2007, I received the 40 Under Forty award from the prestigious international publication Iberian Lawyer for my track record in Commercial and Pharmaceutical Law.

Awards & recognition

Awards & recognition

Héctor Jausàs is a strong pillar in his team as he has a strategic and commercial vision.

Chambers and Partners

Héctor Jausàs stands out for his world on contentious mandates in the Spanish life sciences sector. He regulary advises multinational pharmaceuticals on regulatory, competition and contractual issues. 

Chambers and Partners

Authored pieces

All Resources
Close-up of a laboratory setting featuring a plastic test tube rack and graduated pipettes submerged in water with bubbles surrounding them. The background transitions from pink to blue tones, creating a visually appealing scientific scene.
Life Sciences
Insight

The European Court of Justice opens the way for chemically synthesised generics of reference biological medicinal products

29.04.2026
In a landmark decision issued last Thursday, the Court of Justice of the European Union ruled that a medicines agency may grant a marketing authorisation for a chemically synthesised product as a generic of a reference biological medicinal product. This decision applies across all EU Member States and is expected to have significant implications for the pharmaceutical sector.
Learn more
Press Release

Fieldfisher Spain reports 18% revenue growth, driven by international expansion and cross-selling

12.03.2025
Learn more
Insight

Following in the footsteps of other European countries, new regulation in France has facilitated the development and reimbursement of digital medical devices in this highly promising sector

06.11.2023
Learn more
Press Release

Fieldfisher Spain recognised for leading expertise by Chambers and Partners Europe 2023

29.03.2023
Learn more
Insight

The implementation of the new European Union Clinical trial Regulation

27.01.2022
The regulation of clinical trials across the European Union (EU) will undergo significant changes when the Clinical Trials Regulation (Regulation (EU) No 536/2014) (CTR) comes into application on 31 January 2022.
Learn more